Dividend Declaration

RNS Number : 7252P
Hikma Pharmaceuticals Plc
06 October 2011
 



 

 

 

Hikma Pharmaceuticals PLC

Interim Dividend for 2011

LONDON, 6 October 2011 - Hikma Pharmaceuticals PLC ("the Company") advises that, as previously announced with the interim results, the interim dividend of 5.5 cents per will be paid on 13 October 2011 to shareholders on the register on 9 September 2011. 

Shareholders who have elected to receive their dividend in Pounds Sterling will receive 3.555 pence per Ordinary Share (exchange rate US$1.5470 to GBP£1).

Shareholders who have elected to receive their dividend in Jordanian Dinar will receive 7.768 qirsh (piastres) per Ordinary Share (exchange rate US$0.708 to JOD1).

- ENDS -

Enquiries:

 

Hikma Pharmaceuticals PLC

 

Henry Knowles

Company Secretary

 

+44 20 7399 2670

Susan Ringdal

Investor Relations Director

 

+44 20 7399 2670

 

 

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products.  Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics".  Hikma's operations are based principally in the Middle East and North Africa ("MENA") region, where it is a market leader and sells across 17 countries, the United States and Europe.  In 2010, the Group achieved revenues of $731 million (2009 $637 million) and profit attributable to shareholders was $99 million (2009 $78 million). 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DIVMFBITMBTMBAB
UK 100

Latest directors dealings